Epidarex invests in early-stage, high-growth life science and health technology companies in under-ventured markets within the UK and US.
Epidarex funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today’s healthcare market.
We are trusted partners to our founders and co-investors. We use our deep scientific and industry networks to create exceptional value and shared success.
Epidarex builds the extraordinary.
People
- A. Sinclair Dunlop, Managing Partner
You last contacted this investor on .